Newborn infants are highly susceptible to infection. This defect in host defence has generally been ascribed to the immaturity of neonatal immune cells; however, the degree of hyporesponsiveness is highly variable and depends on the stimulation conditions [1] [2] [3] [4] [5] [6] [7] . These discordant responses illustrate the need for a more unified explanation for why immunity is compromised in neonates. Here we show that physiologically enriched CD71
1 erythroid cells in neonatal mice and human cord blood have distinctive immunosuppressive properties. The production of innate immune protective cytokines by adult cells is diminished after transfer to neonatal mice or after co-culture with neonatal splenocytes. Neonatal CD71
1 cells express the enzyme arginase-2, and arginase activity is essential for the immunosuppressive properties of these cells because molecular inhibition of this enzyme or supplementation with L-arginine overrides immunosuppression. In addition, the ablation of CD71 1 cells in neonatal mice, or the decline in number of these cells as postnatal development progresses parallels the loss of suppression, and restored resistance to the perinatal pathogens Listeria monocytogenes and Escherichia coli 8, 9 . However, CD71
1 cell-mediated susceptibility to infection is counterbalanced by CD71
1 cell-mediated protection against aberrant immune cell activation in the intestine, where colonization with commensal microorganisms occurs swiftly after parturition 10, 11 . Conversely, circumventing such colonization by using antimicrobials or gnotobiotic germ-free mice overrides these protective benefits. Thus, CD71
1 cells quench the excessive inflammation induced by abrupt colonization with commensal microorganisms after parturition. This finding challenges the idea that the susceptibility of neonates to infection reflects immune-cell-intrinsic defects and instead highlights processes that are developmentally more essential and inadvertently mitigate innate immune protection. We anticipate that these results will spark renewed investigation into the need for immunosuppression in neonates, as well as improved strategies for augmenting host defence in this vulnerable population.
Neonates are highly susceptible to disseminated infections, which are often fatal. Numerous distinctions have been described between neonatal and adult responses to infection, including blunted inflammatory cytokine production, skewed T-helper-cell differentiation and fewer protective immune cells; however, the degree of neonatal immune cell hyporesponsiveness varies markedly with the stimulation conditions [1] [2] [3] [4] [5] [6] [7] . Thus, given that neonatal cells have the potential for activation, a more unified explanation is needed for why neonates remain susceptible to infection. We found that the susceptibility of human neonates to infection with the bacterium L. monocytogenes is recapitulated in neonatal mice 8, 12 (Fig. 1a) . Given the delayed immunological development in mice at birth 7, 13 , 6-day-old mice were used as neonates, and their responses were compared with 8-week-old (adult) mice. In addition to diminished survival, over 1,000-fold more L. monocytogenes bacteria were recovered from neonatal mice than from adult mice, and this lack of susceptibility in adults was maintained after adjusting the bacterial inoculation dose proportionally to increased body weight (Fig. 1b) . Accordingly, neonatal mice, like newborn humans, are intrinsically susceptible to disseminated infection.
To investigate the cellular basis of neonatal susceptibility, the effect of adoptively transferring immune cells from adult mice was evaluated ( Fig. 1c and Extended Data Fig. 1a) . We reasoned that if neonatal susceptibility reflects an inadequate number or a hyporesponsiveness of immune cells, then transferred adult cells would restore protection. However, neonates containing adult splenocytes remained equally susceptible to L. monocytogenes infection (Fig. 1d ). Given these somewhat surprising results, the activation of adult cells within neonates was investigated. Because differences in susceptibility between neonatal and adult mice become apparent within 48 h of infection (Fig. 1b) , we focused on essential innate immune protective cytokines such as tumour-necrosis factor-a (TNF-a) [14] [15] [16] . Remarkably, when adult splenocytes containing CD11b 1 granulocyte/macrophage cells, CD11c 1 dendritic cells or B220 1 lymphocytes were transferred to neonatal mice, their TNF-a production induced by L. monocytogenes infection was extinguished to levels comparable to that of endogenous neonatal cells ( Fig. 1e and Extended Data Fig. 1b) . Conversely, TNF-a production by neonatal cells was restored after transfer to L. monocytogenes-infected adult mice (Extended Data Fig. 1c ). These findings suggest that neonatal infection susceptibility might not simply reflect immune-cell-intrinsic defects but instead active suppression within the neonatal environment.
To assess the potential immunosuppressive properties of neonatal cells, the activation and cytokine production of adult immune cells co-cultured with neonatal splenocytes were evaluated. Consistent with the diminished responsiveness of neonatal cells to purified microbial ligands 1, 3, 5, 6 , these cells produced considerably less TNF-a and interleukin-6 (IL-6) after stimulation with heat-killed L. monocytogenes than did adult mouse splenocytes (Fig. 1f) . Similar defects were found for human cord blood cells compared with adult peripheral blood mononuclear cells (Extended Data Fig. 2 ). Interestingly, combining neonatal and adult splenocytes caused a precipitous decline in cytokine production compared with cultures containing only adult cells (Fig. 1f) . Varying the number of neonatal splenocytes in the presence of a fixed quantity of adult cells identified by expression of the congenic marker CD45.1 showed that TNF-a production by adult CD11b 
, CD11c
1 or B220 1 cells was restricted in a dose-dependent manner ( Fig. 2a and Extended Data Fig. 3a) . Immunosuppression also extended to T cells because neonatal splenocytes impeded the upregulation of early activation markers (such as CD69 and CD25) among adult CD8 1 cells after anti-CD3 antibody stimulation ( Fig. 2a and Extended Data Fig. 3b) . Thus, neonatal splenocytes have suppressive properties that recapitulate the blunted activation of adult immune cells within infected neonates.
To establish the molecular basis by which neonatal cells mediate suppression, the effect of inhibitors or neutralizing antibodies on immunomodulatory pathways was evaluated in co-culture. We found that overriding the enzymatic activity of arginase by addition of the inhibitors BEC, ABH, nor-NOHA or L-NOHA, or by supplementation with L-arginine, restored the activation of adult responder cells co-cultured with neonatal splenocytes (Fig. 2b and Extended Data Fig. 4 ). By contrast, the inhibition of other immunomodulatory molecules, including indoleamine 2,3-dioxygenase (IDO), transforming growth factor-b (TGF-b), IL-10 or reactive oxygen species, had no significant effect (Extended Data Fig. 4 ). Importantly, arginase inhibition did not influence TNF-a production by cultures containing only adult cells, illustrating that restored cytokine production was the result of reversing the suppression by neonatal cells. Thus, neonatal splenocytes control immune cell activation through arginine depletion, similarly to the suppressor cells that are associated with tumour progression or persistent infection 17, 18 .
We next sought to define the neonatal splenocyte subset that is responsible for suppression. In contrast to adult mouse splenocytes, ,95% of which express immune lineage markers (CD4, CD8, CD11b, CD11c, B220 and NK1.1), this combination of markers was found on ,35% of neonatal splenocytes (Fig. 2c) . Nearly all of the remaining neonatal splenocytes co-expressed the transferrin receptor (CD71) and the erythroid-lineage-defining molecule TER119 (also known as Ly-76) 19, 20 . Similarly, human cord blood cells contain an equally enriched proportion of CD71 1 cells that co-express the human erythroid marker CD235A, which is in contrast to adult peripheral blood mononuclear cells ( Fig. 2c and Extended Data Fig. 5a ). To establish which subset confers suppression, neonatal splenocytes were fractionated using anti-CD71 antibody or a cocktail of anti-immune-lineage antibodies, and the suppressive properties of each cell population were evaluated in co-culture with adult responder splenocytes. The depletion of CD71
1 cells eliminated the suppression. By contrast, the depletion of immune lineage cells not only retained but also exaggerated the suppression by the remaining CD71
1 cells (Fig. 2d) . Moreover, the depletion of CD71 1 cells are naturally present only in small numbers (Extended Data Fig. 7) . Thus, enriched CD71
1 erythroid cells in neonates suppress systemic immune cell activation. CD71 1 cell ablation was used to further establish the relationship between suppression by these cells and neonatal susceptibility to infection. Although only ,60% depletion could be achieved, significant reductions in the number of recoverable L. monocytogenes bacteria were found after anti-CD71 antibody treatment compared with isotype antibody treatment (Fig. 3a) . The protective benefits of CD71 1 cell depletion in neonates similarly extended to E. coli infection (Extended Data Fig. 8) . Likewise, the physiological contraction of the CD71 1 cell population as postnatal development progressed paralleled the gradual restoration of protection against infection to adult levels. At 6 and 9 days after parturition, mice had equally high CD71
1 cell numbers and comparable numbers of recoverable bacteria after infection. By contrast, 15-dayold mice had ,60% fewer CD71 1 cells and a 100-fold lower pathogen burden. In 21-day-old mice, CD71
1 cell numbers had declined to levels comparable to those of adult mice, and pathogen burden was undetectable (Fig. 3b, c) . The progressive reduction in susceptibility to infection with the decline in CD71 1 cell numbers (as postnatal development progressed) also paralleled the loss of immunosuppressive properties among unfractionated splenocytes (Fig. 3d) . Thus, enriched CD71 1 cells dictate neonatal infection susceptibility, because protection is restored by antibody-mediated depletion of these cells or by their natural disappearance during postnatal development.
To determine whether suppression by CD71 1 cells extends beyond the neonatal period, infection susceptibility after phlebotomy-induced anaemia, with ensuing erythroid cell population expansion, was evaluated in adult mice. Although anaemia efficiently induced CD71 1 TER119 1 cell accumulation, with subsets comparable to those of neonatal splenocytes 21 , there were no significant shifts in infection susceptibility (Extended Data Fig. 9 ), and purified adult CD71 1 cells showed no immunosuppressive properties in co-culture assays (Fig. 3e) . The lack of suppression by adult CD71 1 cells paralleled the markedly lower arginase-2 expression in these cells than in neonatal CD71
1 cells (Fig. 3f ) and the necessity for arginase enzymatic activity for suppression by neonatal splenocytes (Fig. 2b) . Thus, suppression by CD71 1 cells is likely to be restricted to the population that is naturally enriched in neonates. These findings are consistent with the lack of susceptibility to infection among individuals with ailments that accelerate erythropoiesis (for example, thalassaemia and spherocytosis) after the neonatal period, as well as the immunomodulatory properties of other 
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erythroid cell subsets and the remarkable diversity in gene expression among neonatal erythroid precursor cells compared with adult erythroid precursor cells [22] [23] [24] [25] [26] [27] [28] .
Although these results establish that CD71
1 cells impair neonatal host defence against infection, they also raise exciting new questions about why suppressive cells are temporally enriched in neonates. One possibility is to avert the excessive inflammation that might otherwise occur with the abrupt transition from a sterile in utero setting to colonization with commensal microbes in the external environment 29 . This idea is supported by the finding that intestinal immune cells in neonatal mice are selectively activated by anti-CD71 antibody but not by isotype control antibody, as well as by the rapid, intensifying colonization of the intestine with commensal microbes in the first week after birth 10, 11 ( Fig. 4a-c) . In particular, intestinal CD11b 1 and CD11c 1 cells from CD71 1 cell-depleted neonatal mice produce significantly more TNF-a and upregulate expression of the co-stimulatory molecules CD40, CD80 and CD86 more than analogous cells from neonatal mice treated with isotype control antibody (Fig. 4a, b and Extended Data Fig. 10a) . By contrast, after CD71
1 cell depletion, these activation parameters did not change in cell populations from the spleen or 
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lung, which remain sterile or become colonized with considerably fewer commensal bacteria than the intestine (Fig. 4b, c and Extended Data  Fig. 10a ).
Antimicrobials were used to further investigate the relationship between commensal bacteria and CD71
1 cell-mediated protection against aberrant intestinal immune cell activation. We found that a defined antibiotic cocktail that eradicated intestinal bacteria when administered to the drinking water of pregnant mice also prevented colonization in neonates 30 ( Fig. 4c) . Eliminating commensal bacteria, in turn, abolished the increase in TNF-a production and co-stimulatory molecule expression induced by CD71 1 cell depletion ( Fig. 4d and Extended Data Fig. 10b ). To more definitively establish the necessity for commensal microbes in promoting intestinal inflammation, cell activation induced by CD71
1 cell depletion was further addressed using germ-free mice. Although CD71
1 cells were equally enriched in gnotobiotic neonatal mice and conventional neonatal mice, their depletion from gnotobiotic germ-free mice did not induce significant changes in intestinal immune cell activation, similarly to antibiotic treatment (Fig. 4e, f and Extended Data Fig. 10c) . Thus, neonatal CD71 1 erythroid cells protect against excessive inflammation triggered by commensal microbes, whereas their elimination (by using antimicrobials or under germ-free conditions) alleviates these protective benefits.
Taken together, our results demonstrate that neonatal infection susceptibility results from the temporal presence of enriched immunosuppressive CD71 1 cells and is an unfortunate by-product of the greater benefits of active suppression during this crucial developmental period, when tolerance to commensal microbes is more uniformly advantageous. We anticipate that these findings will spur renewed investigation of why neonatal protection against infection is compromised, as well as the study of therapeutic approaches aimed at dissociating the beneficial and harmful effects of CD71 1 cells for augmenting host defence in this vulnerable population.
METHODS SUMMARY
Pregnant C57BL/6 mice were checked twice daily for birth timing. For infection, mice were inoculated intraperitoneally with L. monocytogenes or E. coli, and susceptibility was determined by counting the number of CFU arising from dilutions of organ homogenate spread onto agar plates. For cell transfer, splenocytes from congenic donors were injected into recipients 1 day before infection. For co-culture, adult splenocytes were seeded with neonatal cells and stimulated with either heatkilled L. monocytogenes or anti-CD3 antibody. For depletion, 150 mg anti-CD71 antibody (8D3, AbD Serotec) or isotype control antibody was administered on days 5 and 6 after birth. Differences in survival were compared using the MantelCox log-rank test. Differences in the number of CFU, the cytokine levels and the cell activation levels between separate groups or related groups were analysed using an unpaired or paired Student's t-test, respectively.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. 1 cells prevent aberrant immune cell activation in tissue that is rapidly colonized with commensal microbes. a, TNF-a production by intestinal immune cells from 8-day-old mice treated with anti-CD71 antibody (or isotype control antibody (rat IgG)) on days 5 and 6. b, TNF-a production by cells recovered from the indicated tissues after anti-CD71 antibody treatment of neonatal mice (normalized to the values from isotype-control-antibody-treated neonatal mice). c, The number of recoverable bacteria (CFU) from intestine (brown), spleen (red) and lung (blue) of fetal (embryonic day (E) 18.5) and neonatal mice in the indicated age (days post parturition (PP)) after housing with unsupplemented drinking water or drinking water containing antibiotics (ampicillin, gentamicin, metronidazole, neomycin and vancomycin) from E14.5 (n 5 6-18 mice per time point). d, TNF-a production by cells recovered from the indicated tissues of neonatal mice sustained on antimicrobial therapy and treated with anti-CD71 antibody (normalized to the values from isotype-control-antibody-treated neonatal mice sustained on antimicrobial therapy). e, The proportion of splenocytes that are CD71
1

TER119
1 in 8-day-old conventional and germ-free mice. f, TNF-a production by cells recovered from the indicated tissues of germ-free neonatal mice treated with anti-CD71 antibody (normalized to the values from isotype-control-antibody-treated germ-free neonatal mice). Each point represents data from an individual mouse, and the data are representative of three independent experiments. Error bars, mean 6 s.e.m.
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